Hospital price transparency rule updates for 2025 could help identify less expensive providers

Neumora antidepressant stumbles in Phase 3 readout

January 2, 2025 Check out STAT+

Sponsored By

Adobe STAT+ | Latest updates to hospital price transparency rules aim to make the data more useful Experts are hopeful the price transparency changes will make the data more helpful in identifying less expensive providers. By Tara Bannow Opinion: Save the Food and Drug Administration by breaking it up Splitting the FDA in two will help rebuild trust and allow the new agencies to focus on what they do best. By Lee D. Cooper STAT+ | Neumora's antidepressant stumbles in first Phase 3 trial readout The drug, navacaprant, failed to show a meaningful improvement in depression scores compared to placebo, the company said. By Allison DeAngelis

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser